Kafi Reza, Kwak Heh Shin R, Schumacher Wendy E, Cho Soyun, Hanft Valerie N, Hamilton Ted A, King Anya L, Neal Jacqueline D, Varani James, Fisher Gary J, Voorhees John J, Kang Sewon
Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Arch Dermatol. 2007 May;143(5):606-12. doi: 10.1001/archderm.143.5.606.
To evaluate the effectiveness of topical retinol (vitamin A) in improving the clinical signs of naturally aged skin.
Randomized, double-blind, vehicle-controlled, left and right arm comparison study.
Academic referral center.
The study population comprised 36 elderly subjects (mean age, 87 years), residing in 2 senior citizen facilities.
Topical 0.4% retinol lotion or its vehicle was applied at each visit by study personnel to either the right or the left arm, up to 3 times a week for 24 weeks.
Clinical assessment using a semiquantitative scale (0, none; 9, most severe) and biochemical measurements from skin biopsy specimens obtained from treated areas.
After 24 weeks, an intent-to-treat analysis using the last-observation-carried-forward method revealed that there were significant differences between retinol-treated and vehicle-treated skin for changes in fine wrinkling scores (-1.64 [95% CI, -2.06 to -1.22] vs -0.08 [95% CI, -0.17 to 0.01]; P<.001). As measured in a subgroup, retinol treatment significantly increased glycosaminoglycan expression (P = .02 [n = 6]) and procollagen I immunostaining (P = .049 [n = 4]) compared with vehicle.
Topical retinol improves fine wrinkles associated with natural aging. Significant induction of glycosaminoglycan, which is known to retain substantial water, and increased collagen production are most likely responsible for wrinkle effacement. With greater skin matrix synthesis, retinol-treated aged skin is more likely to withstand skin injury and ulcer formation along with improved appearance.
评估外用视黄醇(维生素A)改善自然衰老皮肤临床症状的有效性。
随机、双盲、赋形剂对照、左右臂比较研究。
学术转诊中心。
研究人群包括36名老年受试者(平均年龄87岁),居住在2家老年设施中。
研究人员每次就诊时将0.4%视黄醇外用洗剂或其赋形剂涂于右臂或左臂,每周最多3次,共24周。
使用半定量量表(0分,无;9分,最严重)进行临床评估,并对治疗部位获取的皮肤活检标本进行生化检测。
24周后,采用末次观察结转法进行的意向性分析显示,视黄醇治疗组和赋形剂治疗组皮肤在细纹评分变化方面存在显著差异(-1.64[95%CI,-2.06至-1.22]对-0.08[95%CI,-0.17至0.01];P<0.001)。在一个亚组中进行测量,与赋形剂相比,视黄醇治疗显著增加了糖胺聚糖表达(P = 0.02[n = 6])和I型前胶原免疫染色(P = 0.049[n = 4])。
外用视黄醇可改善与自然衰老相关的细纹。已知能保留大量水分的糖胺聚糖的显著诱导以及胶原蛋白生成的增加最有可能是皱纹消退的原因。随着皮肤基质合成增加,视黄醇治疗的衰老皮肤更有可能抵抗皮肤损伤和溃疡形成,同时外观得到改善。